Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes
Brief Summary: The aim of the present study is to investigate the influence of several anti-diabetic regimens (metformin,glitazone,sulfonylurea,glinidine) and diet on metabolic parameters in patients with recently diagnosed type 2 diabetes.


Options:
A: Arm Label: Metformin,lifestyle counselling; Type: ACTIVE_COMPARATOR; Interventions: Drug: rosiglitazone, Drug: metformin, Drug: Anti-diabetic medications | Intervention Type: DRUG; Name: rosiglitazone; Assigned to Arm(s): Metformin,lifestyle counselling | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): Metformin,lifestyle counselling | Intervention Type: DRUG; Name: Anti-diabetic medications; Assigned to Arm(s): Metformin,lifestyle counselling
B: Arm Label: 3.0 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Placebo tablet, Drug: Metformin | Arm Label: 2.0 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Placebo tablet, Drug: Metformin | Arm Label: 1.5 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Placebo tablet, Drug: Metformin | Arm Label: 1.0 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Placebo tablet, Drug: Metformin | Arm Label: 0.75 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Placebo tablet, Drug: Metformin | Arm Label: 0.5 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Placebo tablet, Drug: Metformin | Arm Label: 0.25 mg LY2189265; Type: EXPERIMENTAL; Interventions: Drug: LY2189265, Drug: Placebo tablet, Drug: Metformin | Arm Label: Sitagliptin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sitagliptin, Drug: Placebo solution, Drug: Metformin | Arm Label: Placebo/Sitagliptin (Baseline Through 104 Weeks); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo solution, Drug: Placebo tablet, Drug: Metformin | Intervention Type: DRUG; Name: LY2189265; Assigned to Arm(s): 0.25 mg LY2189265, 0.5 mg LY2189265, 0.75 mg LY2189265, 1.0 mg LY2189265, 1.5 mg LY2189265, 2.0 mg LY2189265, 3.0 mg LY2189265 | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Sitagliptin | Intervention Type: DRUG; Name: Placebo solution; Assigned to Arm(s): Placebo/Sitagliptin (Baseline Through 104 Weeks), Sitagliptin | Intervention Type: DRUG; Name: Placebo tablet; Assigned to Arm(s): 0.25 mg LY2189265, 0.5 mg LY2189265, 0.75 mg LY2189265, 1.0 mg LY2189265, 1.5 mg LY2189265, 2.0 mg LY2189265, 3.0 mg LY2189265, Placebo/Sitagliptin (Baseline Through 104 Weeks) | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): 0.25 mg LY2189265, 0.5 mg LY2189265, 0.75 mg LY2189265, 1.0 mg LY2189265, 1.5 mg LY2189265, 2.0 mg LY2189265, 3.0 mg LY2189265, Placebo/Sitagliptin (Baseline Through 104 Weeks), Sitagliptin
C: Arm Label: Saxagliptin + Metformin (A); Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin + Metformin, Drug: Pioglitazone | Arm Label: Saxagliptin + Metformin (B); Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin + Metformin, Drug: Pioglitazone | Arm Label: Saxagliptin + Metformin (C); Type: EXPERIMENTAL; Interventions: Drug: Saxagliptin + Metformin, Drug: Pioglitazone | Arm Label: Placebo+ Metformin (D); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo + Metformin, Drug: Pioglitazone | Intervention Type: DRUG; Name: Saxagliptin + Metformin; Assigned to Arm(s): Saxagliptin + Metformin (A) | Intervention Type: DRUG; Name: Saxagliptin + Metformin; Assigned to Arm(s): Saxagliptin + Metformin (B) | Intervention Type: DRUG; Name: Saxagliptin + Metformin; Assigned to Arm(s): Saxagliptin + Metformin (C) | Intervention Type: DRUG; Name: Placebo + Metformin; Assigned to Arm(s): Placebo+ Metformin (D) | Intervention Type: DRUG; Name: Pioglitazone; Assigned to Arm(s): Placebo+ Metformin (D), Saxagliptin + Metformin (A), Saxagliptin + Metformin (B), Saxagliptin + Metformin (C)
D: Arm Label: Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: Vildagliptin; Type: EXPERIMENTAL; Interventions: Drug: Vildagliptin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Vildagliptin; Assigned to Arm(s): Vildagliptin

Answer: A